Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OncoTrust Biotech is a Taiwan-based precision medicine company specializing in liquid biopsy and advanced molecular diagnostics. The company focuses on the detection and monitoring of cancer through non-invasive blood tests, utilizing proprietary technologies for circulating tumor cell (CTC) and cell-free DNA (cfDNA) analysis. Their services aim to provide clinicians with actionable insights for personalized treatment planning, early cancer screening, and post-treatment recurrence monitoring. OncoTrust integrates bioinformatics and clinical validation to improve patient outcomes in oncology. The company operates a certified laboratory to deliver high-quality genomic profiling services to hospitals and research institutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 安新生醫.